The major findings of this study are as follows: (a) PI16 decreases CF proliferation and Ang II–induced fibrotic marker protein expression by regulating HDAC1/p53 signalling; (b) highly expressed PI16 in CFs attenuates cardiac hypertrophy and fibrosis induced by Ang II. Here, PI16 is linked to cardiac hypertrophy.